| Product Code: ETC7765763 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Jordan Onco-hematology Molecular Testing Market Overview |
3.1 Jordan Country Macro Economic Indicators |
3.2 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Jordan Onco-hematology Molecular Testing Market - Industry Life Cycle |
3.4 Jordan Onco-hematology Molecular Testing Market - Porter's Five Forces |
3.5 Jordan Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Type, 2021 & 2031F |
3.6 Jordan Onco-hematology Molecular Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Jordan Onco-hematology Molecular Testing Market Revenues & Volume Share, By Blood Cancer Biomarker, 2021 & 2031F |
3.8 Jordan Onco-hematology Molecular Testing Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Jordan Onco-hematology Molecular Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and hematological disorders in Jordan |
4.2.2 Growing awareness about the importance of early detection and personalized treatment in oncology and hematology |
4.2.3 Advancements in molecular testing technologies leading to more accurate and efficient diagnostics |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and expertise in onco-hematology molecular testing in Jordan |
4.3.2 High costs associated with molecular testing procedures and equipment |
4.3.3 Regulatory challenges and lack of standardized guidelines for molecular testing in onco-hematology in Jordan |
5 Jordan Onco-hematology Molecular Testing Market Trends |
6 Jordan Onco-hematology Molecular Testing Market, By Types |
6.1 Jordan Onco-hematology Molecular Testing Market, By Blood Cancer Type |
6.1.1 Overview and Analysis |
6.1.2 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Blood Cancer Type, 2021- 2031F |
6.1.3 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021- 2031F |
6.1.4 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Myeloproliferative Neoplasms, 2021- 2031F |
6.1.5 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Myeloid Leukemia, 2021- 2031F |
6.1.6 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F |
6.2 Jordan Onco-hematology Molecular Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By qPCR, 2021- 2031F |
6.2.3 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By dPCR, 2021- 2031F |
6.2.4 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Next-Generation Sequencing, 2021- 2031F |
6.2.5 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Jordan Onco-hematology Molecular Testing Market, By Blood Cancer Biomarker |
6.3.1 Overview and Analysis |
6.3.2 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By BCR-ABL1 Mbcr, 2021- 2031F |
6.3.3 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By JAK2, 2021- 2031F |
6.3.4 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By CALR, 2021- 2031F |
6.3.5 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By MPL, 2021- 2031F |
6.3.6 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By PML-RARA, 2021- 2031F |
6.3.7 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By NPM1, 2021- 2031F |
6.3.8 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.3.9 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By CBFB-MYH11, 2021- 2031F |
6.4 Jordan Onco-hematology Molecular Testing Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By National Reference Lab / Specialty Lab, 2021- 2031F |
6.4.3 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By University Hospital / Oncology Center, 2021- 2031F |
6.4.4 Jordan Onco-hematology Molecular Testing Market Revenues & Volume, By Community Hospital / IDN (Regional/National), 2021- 2031F |
7 Jordan Onco-hematology Molecular Testing Market Import-Export Trade Statistics |
7.1 Jordan Onco-hematology Molecular Testing Market Export to Major Countries |
7.2 Jordan Onco-hematology Molecular Testing Market Imports from Major Countries |
8 Jordan Onco-hematology Molecular Testing Market Key Performance Indicators |
8.1 Average turnaround time for onco-hematology molecular testing |
8.2 Rate of adoption of new molecular testing technologies in Jordan |
8.3 Number of partnerships between healthcare providers and molecular testing companies in the onco-hematology space |
9 Jordan Onco-hematology Molecular Testing Market - Opportunity Assessment |
9.1 Jordan Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Type, 2021 & 2031F |
9.2 Jordan Onco-hematology Molecular Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Jordan Onco-hematology Molecular Testing Market Opportunity Assessment, By Blood Cancer Biomarker, 2021 & 2031F |
9.4 Jordan Onco-hematology Molecular Testing Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Jordan Onco-hematology Molecular Testing Market - Competitive Landscape |
10.1 Jordan Onco-hematology Molecular Testing Market Revenue Share, By Companies, 2024 |
10.2 Jordan Onco-hematology Molecular Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here